GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RAMM Pharma Corp (XCNQ:RAMM) » Definitions » Short Percentage of Float

RAMM Pharma (XCNQ:RAMM) Short Percentage of Float


View and export this data going back to 2019. Start your Free Trial

What is RAMM Pharma Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of RAMM Pharma's Short Percentage of Float

For the Drug Manufacturers - Specialty & Generic subindustry, RAMM Pharma's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RAMM Pharma's Short Percentage of Float Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RAMM Pharma's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where RAMM Pharma's Short Percentage of Float falls into.


;
;

RAMM Pharma Business Description

Traded in Other Exchanges
N/A
Address
82 Richmond Street E, Toronto, ON, CAN, M5C 1P1
RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.
Executives
Jackie Peter Burnett 10% Security Holder, Director, Senior Officer
Armando Gabriel Blankleider Director

RAMM Pharma Headlines

No Headlines